The largest database of trusted experimental protocols

Acquity uplc ms system

Manufactured by Waters Corporation
Sourced in United States

The Acquity UPLC/MS system is a liquid chromatography-mass spectrometry (LC-MS) instrument designed for high-performance separation and detection of compounds. It features ultra-high-pressure liquid chromatography (UPLC) technology to achieve rapid and efficient separations, coupled with a mass spectrometer for sensitive and selective analyte identification and quantification.

Automatically generated - may contain errors

16 protocols using acquity uplc ms system

1

In Vitro Release of PPT from Serum

Check if the same lab product or an alternative is used in the 5 most similar protocols
PPT-NPs were 1:1 (v:v) mixed with fetal bovine serum (FBS) at the final concentration of 100 µg PPT /mL. Samples were incubated at 37 °C, and at selected time points triplicate samples were removed and serum protein was precipitated using 600 µL MeCN containing 1% acetic acid. The sample was centrifuged for 5 min at 10,000 rpm and the supernatant was analyzed for released PPT by a Waters Acquity UPLC/MS system equipped with a PDA and SQ MS detector. The samples were injected into an Agilent XDB-C18 column (1.8 µm, 4.6 × 50 mm) at a flow rate of 0.4 mL/min, with a gradient program of 95/5 to 10/90 water/MeCN over 5 min. A calibration curve for PPT was prepared by spiking known amounts of PPT in a saline/FBS mixture, followed by the same extraction protocol.
+ Open protocol
+ Expand
2

Kinetic Stability of Compound NU-1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Assay was conducted as described with minor modifications.37 (link) Briefly, a 1 mM stock solution of NU-1 with internal standard (phenacetin) in DMSO was added to a 50 mM solution of either N-acetyl cysteine, N-acetyl lysine or N-acetyl serine in 67 mM phosphate buffer (pH 7.4), as well as added to a solution of 67 mM phosphate buffer (pH 7.4) control. Samples were taken every 2 min for 2 h and quenched immediately with MeOH and centrifuged upon sampling. Samples were placed on a Waters Acquity UPLC-MS system and measured for the ratio of NU-1 to internal standard intensity to calculate the amount of NU-1 present at each time point relative to the amount of NU-1 at the first injection of the compound in buffer. Assay was conducted in triplicate.
+ Open protocol
+ Expand
3

Purification of Organic Compounds via UPLC-MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Starting materials, reagents, and solvents were purchased from commercial suppliers and were used without further purification unless otherwise noted. All reactions were monitored using a Waters Acquity UPLC/MS system (Waters PDA eλ Detector, QDa Detector, Sample manager - FL, Binary Solvent Manager) using Acquity UPLC® BEH C18 column (2.1 × 50 mm, 1.7 μm particle size): solvent gradient = 85 % A at 0 min, 1 % A at 1.7 min; solvent A = 0.1 % formic acid in Water; solvent B = 0.1 % formic acid in acetonitrile; flow rate : 0.6 mL/min. Reaction products were purified by flash column chromatography using CombiFlash®Rf with Teledyne Isco RediSep® normal-phase silica flash columns (4 g, 12 g, 24 g, 40 g or 80 g) and Waters HPLC system using SunFire Prep C18 column (19 × 100 mm, 5 μm particle size): solvent gradient = 80 % A at 0 min, 10 % A at 25 min; solvent A = 0.035 % TFA in Water; solvent B = 0.035 % TFA in MeOH; flow rate : 25 mL/min. 1H NMR spectra were recorded on 500 MHz Bruker Avance III spectrometers and 13C NMR spectra were recorded on 125 MHz Bruker Avance III spectrometer. Chemical shifts are reported in parts per million (ppm, δ) downfield from tetramethylsilane (TMS). Coupling constants (J) are reported in Hz. Spin multiplicities are described as br (broad), s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet).
+ Open protocol
+ Expand
4

HPLC-MS Amino Acid Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The samples were analyzed in a Waters 2695 HPLC system (Waters Co., Milford, MA, USA) fitted with a Diomansil C18 column (4.6 mm × 250 mm). The chromatographic conditions were as follows: mobile phase A (NaAc-HAc buffer (50 mM, pH 4.2):acetonitrile = 50:50); mobile phase B (acetonitrile); gradient elution program; flow rate, 1 mL min−1; column temperature, 25 °C; injection volume, 10 µL. Post-column derivatization was conducted with Fmoc-Cl [44 (link)]. The Fmoc-Cl derivatives of the amino acids were detected at 263 nm.
LC-MS analysis was conducted in a Waters ACQUITY UPLC-MS system fitted with a Waters ACQUITY UPLC HSS C18 reverse-phase column (inner diameter, 1.8 µm) (Waters Co., Milford, MA, USA). The inlet, MS transfer line, and ion source temperatures were set to 280, 280, and 230 °C, respectively.
+ Open protocol
+ Expand
5

Quantification of Glycyrrhizin Derivatives

Check if the same lab product or an alternative is used in the 5 most similar protocols
The reaction products were detected with the ACQUITY UPLC/MS system (Waters, Milford, MA, USA) in electrospray ionization negative ion mode with selected ion monitoring, as described in Method S5. The amount of reaction products was determined as the peak area using MassLynx software (Waters). The kinetic parameters were calculated by fitting a Michaelis–Menten curve to the raw kinetic data using GraphPad Prism 6.0h software (GraphPad Software, San Diego, CA, USA). The raw data were calibrated beforehand with standard curves of authentic glycyrrhizin and glucoglycyrrhizin.
+ Open protocol
+ Expand
6

Purification and Characterization of Organic Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Reagents and solvents were purchased from commercial sources (Fisher, Sigma-Aldrich, Combi-Blocks and Suzhou Medinoah Ltd) and used as received. Reactions were tracked by TLC (Silica gel 60 F254, Merck) and Waters ACQUITY UPLC-MS system (ACQUITY UPLC H Class Plus in tandem with QDa Mass Detector). Intermediates and products were purified by a Teledyne ISCO Combi-Flash system using prepacked SiO2 cartridges. NMR spectra were acquired on a Bruker AV400 or AV500 instrument (500 MHz for 1H NMR, 126 MHz for 13C NMR). 13C shifts were obtained with 1H decoupling. MestReNova 14.0.1 developed by MESTRELAB RESEARCH was used for NMR data processing. MS-ESI spectra were recorded on Waters QDa Mass Detector. The UPLC-MS was performed on a Waters BEH C18 column (2.1 mm × 50 mm, 1.7 μm) with peak detection at UV 254 nm (mobile phase: acetonitrile and 0.1% formic acid in water; gradient: 0–5 min, 2–98% acetonitrile). Purities of final compounds were assessed by UPLC-MS. All compounds are > 95% pure by UPLC analysis.
+ Open protocol
+ Expand
7

UPLC-MS Metabolite Extraction and Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Extracted metabolites were detected using the ACQUITY UPLC/MS system (Waters, Milford, MA, USA) with an ACQUITY UPLC HSS C18 column (2.1 × 150-mm column and 2.1 × 5-mm VanGuard pre-column; particle size, 1.8 μm, Waters, Milford, MA, USA) and an ACQUITY TQ Detector (Waters) in electrospray ionisation negative-ion mode with selected-ion monitoring (SIM). The mobile phase was composed of 0.025% (v/v) acetic acid in water (solvent 1) and 0.025% (v/v) acetic acid in acetonitrile (solvent 2). Samples were separated via gradient elution with 30% solvent 2 for 6 min to 100% over 22 min (40% at 6 min, 50% at 18 min and 100% at 28 min) at a flow rate of 0.20 mL/min. The final condition was maintained for 3.5 min and returned to the initial condition, resulting in a total chromatography run time of 38.5 min. The sample manager and the column were kept at 15 °C and 30 °C, respectively. For MS detection, the capillary voltage was set to 2.5 kV, cone voltage to 80 V, extractor voltage to 3 V, source temperature to 150 °C, desolvation temperature to 350 °C, cone gas flow to 50 L/h and desolvation gas flow to 600 L/h. The quantities of extracted compounds of interest were determined from the peak areas using MassLynx software (Waters). The values used for SIM for each assay are listed in Supplementary Table 4.
+ Open protocol
+ Expand
8

Proteasome Inhibitor Characterization Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The fluorogenic substrate Suc-LLVY-AMC, Z-LLE-AMC, and Z-VLR-AMC were from Boston Biochem (Cambridge, MA). Human immunoproteasomes (i-20S, isolated from peripheral blood mononuclear cells), human constitutive proteasomes (c-20S, isolated from red blood cells), and recombinant human PA28 activator alpha subunit (PA28α) were from Boston Biochem Inc. Mtb20SOG was expressed and purified as reported.27 (link) Mouse and human liver microsomes were purchased from Sekisui XenoTech, LLC. (Kansas City, KS). Purity of the compounds was determined on a Waters Acquity UPLC / MS system equipped with a C18 column (100 × 2.1 mm, 1.7 μm), coupled with a PDA detector. The purity of all final compounds was > 95% except macrocycle 13. The purity of macrocycle 13 was 93%.
+ Open protocol
+ Expand
9

Aqueous Kinetic Solubility Determination

Check if the same lab product or an alternative is used in the 5 most similar protocols
The aqueous kinetic
solubility was determined from a 10 mM DMSO stock solution of test
compound (39 or 50) in PBS buffer at pH
7.4. The study was performed by incubating an aliquot of 10 mM DMSO
stock solution in PBS (pH 7.4) to a target concentration of 250 μM
(2.5% DMSO). The incubation was carried out under shaking at 25 °C
for 24 h, followed by centrifugation at 21,100g for
30 min. The supernatant was further diluted (4:1) with CH3CN, and the dissolved test compound was quantified by UV at 215 nm
on a Waters ACQUITY UPLC-MS system consisting of a single quadrupole
detector (SQD) mass spectrometer equipped with an electrospray ionization
interface and a photodiode array detector (PDA) from Waters Inc. (Milford,
MA, USA). Electrospray ionization in positive mode was used in the
mass scan range 100–500 Da. The PDA range was 210–400
nm. The analyses were run on an ACQUITY UPLC BEH C18 column (50 ×
2.1 mm ID, particle size 1.7 μm) with a VanGuard BEH C18 precolumn
(5 × 2.1 mm ID, particle size 1.7 μm), using 10 mM NH4OAc in H2O at pH 5 adjusted with AcOH (A) and 10
mM NH4OAc in CN–H2O (95:5) at pH 5 (B)
as the mobile phase. The aqueous kinetic solubility (in μM)
was calculated by dividing the peak areas of dissolved test compound
and test compound in the reference (250 μM of test compound
in CH3CN) and multiplying by the target concentration and
dilution factor.
+ Open protocol
+ Expand
10

UPLC/MS Purity Analysis of Compound 5

Check if the same lab product or an alternative is used in the 5 most similar protocols
All the
tested compounds
were >95% pure. Compound 5 displayed ≥99% purity as determined
by UPLC/MS analysis (Supporting Information Purity of compound 5). 10 mM stock solution of Compound 5 was prepared
in DMSO-d6 and further diluted 20-fold
with CH3CN–H2O (1:1) for analysis. The
QC analyses were performed on a Waters ACQUITY UPLC/MS system consisting
of a SQD (Single Quadrupole Detector) Mass Spectrometer equipped with
an electrospray ionization interface and a photodiode array detector.
Electrospray ionization in positive and negative modes was applied
in the mass scan range 100–500 Da. The PDA range was 210–400
nm. The analyses were run on an ACQUITY UPLC BEH C18 column (100 ×
2.1 mm ID, particle size 1.7 μm) with a VanGuard BEH C18 pre-column
(5 × 2.1 mm ID, particle size 1.7 μm). The mobile phase
was 10 mM NH4OAc in H2O at pH 5 adjusted with
AcOH (A) and 10 mM NH4OAc in CH3CN–H2O (95:5) at pH 5 (B) with 0.5 mL/min as flow rate. A linear
gradient was applied: 0–0.2 min: 10% B, 0.2–6.2 min:
10–90% B, 6.2–6.3 min: 90–100%, 6.3–7.0
min: 100% B.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!